APOBEC3B and breast carcinoma: In line with these findings, high levels of APOBEC3B mRNA were associated with a shorter disease-free survival in ER-positive, LNN, systemically untreated patients, as well as with earlier recurrence in luminal subtype patients and with a more aggressive phenotype in Japanese breast cancers [15–17].